120 related articles for article (PubMed ID: 3993434)
1. Effects of secretin on parathyroid hormone and calcium in normal subjects, patients with hyperparathyroidism and patients with gastrinoma.
Benson L; Lundqvist G; Wide L; Akerström G; Oberg K; Ljunghall S
Acta Med Scand; 1985; 217(2):205-11. PubMed ID: 3993434
[TBL] [Abstract][Full Text] [Related]
2. Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome.
Jansen JB; Lamers CB
Gastroenterology; 1982 Jul; 83(1 Pt 2):173-8. PubMed ID: 6806138
[TBL] [Abstract][Full Text] [Related]
3. Hyperparathyroidism and hypergastrinemia revisited.
Primrose JN; Joffe SN
Surgery; 1984 Dec; 96(6):1144-50. PubMed ID: 6505967
[TBL] [Abstract][Full Text] [Related]
4. The relationship of the serum gastrin and calcium concentrations in patients with multiple endocrine neoplasia type I.
Thompson MH; Sanders DJ; Grund ER
Br J Surg; 1976 Oct; 63(10):779-83. PubMed ID: 11029
[TBL] [Abstract][Full Text] [Related]
5. Calcium and parathyroid hormone behaviour after exogenous secretin infusion in man.
Lo Cascio V; Piubello W; Cominacini L; Vantini I; Galvanini G; Ederle A; Cavallini G; Scuro LA
Clin Endocrinol (Oxf); 1982 Apr; 16(4):331-6. PubMed ID: 7094360
[TBL] [Abstract][Full Text] [Related]
6. Lack of effect of parathyroidectomy or calcium channel blockade on serum gastrin concentration and gastric acid secretion in a patient with hyperparathyroidism and Zollinger-Ellison syndrome.
Stevens MH; Thirlby RC; Richardson CT
Surgery; 1987 Jan; 101(1):108-13. PubMed ID: 3798319
[TBL] [Abstract][Full Text] [Related]
7. Gastric secretion and hormonal interactions in multiple endocrine neoplasia type I.
Gogel HK; Buckman MT; Cadieux D; McCarthy DM
Arch Intern Med; 1985 May; 145(5):855-9. PubMed ID: 2859842
[TBL] [Abstract][Full Text] [Related]
8. Fasting serum gastrin in primary hyperparathyroidism and in chronic hypercalcemia.
Vantini I; Cominacini L; Ederle A; Galvanini G; Piubello W; Adami S; Cavallini G; Lo Cascio V
Acta Hepatogastroenterol (Stuttg); 1979 Dec; 26(6):472-7. PubMed ID: 549429
[TBL] [Abstract][Full Text] [Related]
9. Normal pattern of parathyroid response to blood calcium lowering in primary hyperparathyroidism: a citrate clamp study.
Schwarz P; Sørensen HA; Momsen G; McNair P; Transbøl I
Clin Endocrinol (Oxf); 1992 Oct; 37(4):344-8. PubMed ID: 1483290
[TBL] [Abstract][Full Text] [Related]
10. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study.
Frucht H; Howard JM; Slaff JI; Wank SA; McCarthy DM; Maton PN; Vinayek R; Gardner JD; Jensen RT
Ann Intern Med; 1989 Nov; 111(9):713-22. PubMed ID: 2572194
[TBL] [Abstract][Full Text] [Related]
11. Progressive escape from parathyroid suppression: a common phenomenon in primary hyperparathyroidism (a calcium clamp study).
Sørensen HA; Schwarz P; Hyldstrup L; Transbøl I
Clin Endocrinol (Oxf); 1994 Mar; 40(3):309-15. PubMed ID: 8187293
[TBL] [Abstract][Full Text] [Related]
12. Abnormal pancreatic polypeptide release by secretin infusion in Zollinger-Ellison syndrome.
Rigaud D; Accary JP; Mignon M; Bonfils S
Dig Dis Sci; 1984 Aug; 29(8):696-702. PubMed ID: 6745029
[TBL] [Abstract][Full Text] [Related]
13. Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison.
Cadiot G; Houillier P; Allouch A; Paillard M; Mignon M
Gut; 1996 Aug; 39(2):273-8. PubMed ID: 8977343
[TBL] [Abstract][Full Text] [Related]
14. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.
Malberti F; Farina M; Imbasciati E
Nephrol Dial Transplant; 1999 Oct; 14(10):2398-406. PubMed ID: 10528664
[TBL] [Abstract][Full Text] [Related]
15. Suppression of parathyroid hormone secretion with oral calcium in normal subjects and patients with primary hyperparathyroidism.
Tohme JF; Bilezikian JP; Clemens TL; Silverberg SJ; Shane E; Lindsay R
J Clin Endocrinol Metab; 1990 Apr; 70(4):951-6. PubMed ID: 2318950
[TBL] [Abstract][Full Text] [Related]
16. Secretin-stimulated serum gastrin levels in hyperparathyroid patients from families with multiple endocrine adenomatosis type I.
Lamers CB; Buis JT; van Tongeren J
Ann Intern Med; 1977 Jun; 86(6):719-24. PubMed ID: 17340
[TBL] [Abstract][Full Text] [Related]
17. Regulation of parathyroid hormone release in primary and secondary hyperparathyroidism - studies in vivo and in vitro.
Rudberg C; Akerström G; Ljunghall S; Grimelius L; Johansson H; Pertoft H; Wide L
Acta Endocrinol (Copenh); 1982 Nov; 101(3):408-13. PubMed ID: 7148339
[TBL] [Abstract][Full Text] [Related]
18. Secretin provocation in normal and duodenal ulcer subjects. Is the gastrin rise in Zollinger-Ellison syndrome paradoxic or exaggeration?
Brady CE; Utts SJ; Dev J
Dig Dis Sci; 1987 Mar; 32(3):232-8. PubMed ID: 3816477
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of the value of the calcium, secretin, and meal stimulated increase in serum gastrin to the diagnosis of the Zollinger-Ellison syndrome.
Lamers CG; Van Tongeren JH
Gut; 1977 Feb; 18(2):128-35. PubMed ID: 323117
[TBL] [Abstract][Full Text] [Related]
20. Comparison of four provocative tests for the diagnosis of gastrinoma.
Romanus ME; Neal JA; Dilley WG; Leight GS; Linehan WM; Santen RJ; Farndon JR; Jones RS; Wells SA
Ann Surg; 1983 May; 197(5):608-17. PubMed ID: 6847280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
